RXO Stock Plunges 10.59% on Analyst Downgrades

On April 4, 2025, RXO's stock experienced a significant drop of 10.59% in pre-market trading, reflecting the market's response to recent developments and analyst sentiments.

RXO, Inc. has been under considerable pressure due to multiple analyst downgrades and reduced price targets. These adjustments come in the wake of challenging market conditions and increased economic uncertainty.

Oppenheimer analysts recently downgraded RXO's stock from "Outperform" to "Perform," citing economic concerns and market volatility as key factors influencing their decision.

Susquehanna also contributed to the downward pressure on RXO's stock by lowering their price target from $18.00 to $13.00 and assigning a "negative" rating, further dampening investor confidence.

Despite these challenges, RXO's stock has entered oversold territory, with the Relative Strength Index (RSI) falling below 30, indicating a potential rebound if market conditions improve.